| 000 -LEADER |
|---|
| fixed length control field |
01331cam a22003734a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
13403134 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20130904111740.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
031112s2004 njua b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2003024925 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1588292282 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(DNLM)101197175 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC271.C5 |
| Item number |
A6722 2004 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 269 |
| Item number |
A62953 2004 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
CD 1025 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Anticancer drug development guide : |
| Remainder of title |
preclinical screening, clinical trials, and approval / |
| Statement of responsibility, etc |
edited by Beverly A. Teicher, Paul A. Andrews. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
2nd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Totowa, N.J. : |
| Name of publisher, distributor, etc |
Humana Press, |
| Date of publication, distribution, etc |
c2004. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Accompanying Material of Anticancer drug development guide. |
| 538 ## - SYSTEM DETAILS NOTE |
|---|
| System details note |
Minimum system requirements: Adobe reader 6.0 or later. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antineoplastic agents |
| General subdivision |
Development. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antineoplastic Agents |
| General subdivision |
standards. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Clinical Trials. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Approval. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Design. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Evaluation, Preclinical. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Teicher, Beverly A., |
| Dates associated with a name |
1952- |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Andrews, Paul A. |
| 856 41 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Table of contents |
| Uniform Resource Identifier |
http://www.loc.gov/catdir/toc/ecip0411/2003024925.html |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
http://www.loc.gov/catdir/enhancements/fy0825/2003024925-d.html |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Visual Materials |
| Source of classification or shelving scheme |
|